---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-009160"
form_type: "8-K"
ticker: "HSCS"
cik: "0001468492"
company_name: "HeartSciences Inc."
filed_at: "2024-01-31T23:59:59+00:00"
generated_at: "2026-06-06T13:19:19.133391+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Heart Test Labs gets 180-day Nasdaq bid-price extension; faces delisting if not compliant by July 29, 2024

## Summary
- Nasdaq granted additional 180-day extension to July 29, 2024, to regain $1 minimum bid price compliance.
- Company previously failed minimum bid price based on 30 consecutive business day closing bid.
- If not compliant by deadline, Nasdaq will issue delisting notice; company may appeal.
- Company may implement reverse stock split to regain compliance but provides no assurance.

## SEC filing metadata
- accession: 0000950170-24-009160
- form_type: 8-K
- ticker: HSCS
- cik: 0001468492
- company_name: HeartSciences Inc.
- filed_at: 2024-01-31T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1468492/000095017024009160/0000950170-24-009160-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1468492/000095017024009160/hscs-20240130.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-009160
- JSON: https://secwatch.observer/filing/0000950170-24-009160.json
- Plain text: https://secwatch.observer/filing/0000950170-24-009160.txt

## Key facts
- Listing & Compliance Notices
  HeartSciences Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: extension granted
  - Deficiency: minimum bid price
  - Rules: 5810(c)(3)(A)
  source text: January 30, 2024, the Company received a letter from Nasdaq advising that the Company had been granted an additional 180-day extension to July 29, 2024, to regain compliance with the Minimum Bid Price Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A). If the Company does not regain compliance within the allotted compliance period, Nasdaq staff will provide notice that the Company’s Common Stock will be subject to delisting. The Company would then be entitled to appeal that determination to a Nasdaq hearings panel. The Company will continue to monitor the closing bid price of it
  evidence_url: https://www.sec.gov/Archives/edgar/data/1468492/000095017024009160/0000950170-24-009160-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.